Keywords: درمان ضد انعقاد خوراکی; Oral anticoagulant therapy; Left atrial appendage occlusion; Atrial fibrillation; Dialysis; Thromboembolism; Bleeding;
مقالات ISI درمان ضد انعقاد خوراکی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: درمان ضد انعقاد خوراکی; Non-valvular atrial fibrillation; Prognosis; Von Willebrand factor; Stroke; Cardiovascular events; Fibrillation atriale non valvulaire; Pronostic; Facteur von Willebrand; Infarctus cérébral; Ãvènements cardiovasculaires; AF; atrial fibrillation; CHADS
Keywords: درمان ضد انعقاد خوراکی; Atrial fibrillation; Major bleeding; Restarting; Oral anticoagulant therapy;
Keywords: درمان ضد انعقاد خوراکی; Atrial fibrillation; Dementia; Cognitive decline; Oral anticoagulant therapy; Time in therapeutic range;
Keywords: درمان ضد انعقاد خوراکی; Atrial fibrillation; Stroke prevention; Oral anticoagulant therapy; Direct oral anticoagulants; Vitamin K antagonists; Elderly patients;
Keywords: درمان ضد انعقاد خوراکی; Oral anticoagulant therapy; Thromboembolic risk; Vitamin K antagonist; Non-vitamin K antagonist oral anticoagulants; Clinical characteristics;
Keywords: درمان ضد انعقاد خوراکی; Left atrial appendage; Oral anticoagulant therapy; Warfarin; Atrial fibrillation;
Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study
Keywords: درمان ضد انعقاد خوراکی; CUS; compression ultrasonography; DVT; deep vein thrombosis; FVL; Factor V Leiden; OAT; oral anticoagulant therapy; PE; pulmonary embolism; PGM; prothrombin gene mutation; PVO; percentage of vascular obstruction; RVO; residual vein obstruction; VTE; venou
Guideline-adherent therapy for stroke prevention in atrial fibrillation in different health care settings: Results from RAMSES study
Keywords: درمان ضد انعقاد خوراکی; Atrial fibrillation; Stroke prevention; Oral anticoagulant therapy; Guideline adherence;
Non-permanent atrial fibrillation and oral anticoagulant therapy are related to survival during 10Â years after first-ever ischemic stroke
Keywords: درمان ضد انعقاد خوراکی; Atrial fibrillation; Recurrent AF; Permanent AF; Ischemic stroke; Oral anticoagulant therapy; All-cause mortality;
Vitamin K antagonists favourably modulate fibrin clot properties in patients with atrial fibrillation as early as after 3Â days of treatment: Relation to coagulation factors and thrombin generation
Keywords: درمان ضد انعقاد خوراکی; AF; atrial fibrillation; VKAs; vitamin K antagonists; INR; international normalized ratio; F; factor; PC; protein C; TG; thrombin generation; VKD; vitamin K-dependent; AT; antithrombin; OAT; oral anticoagulant therapy; CLT; clot lysis time; ETP; endogenou
Quality of life assessment in children commencing home INR self-testing
Keywords: درمان ضد انعقاد خوراکی; HRQoL; health-related quality of life; ICC; intraclass correlation coefficient; INR; International Normalised Ratio; MCID; minimal clinically important difference; OAT; oral anticoagulant therapy; PAC QL©; Pediatric Anticoagulation Quality of Life invent
Traitement préventif non médicamenteux des accidents thromboemboliques (AVC ischémiques)
Keywords: درمان ضد انعقاد خوراکی; Accident vasculaire cérébral; Auricule gauche; Fibrillation auriculaire; Fermeture percutanée; Risque hémorragique; Traitement anticoagulantStroke; Left atrium appendage; Percutaneous closure; Atrial fibrillation; Oral anticoagulant therapy; Bleeding risk
Carotid Revascularization in Patients with Ongoing Oral Anticoagulant Therapy: The Advantages of Stent Placement
Keywords: درمان ضد انعقاد خوراکی; ASA; acetylsalicylic acid; CAS; carotid artery stenting; CEA; carotid endarterectomy; INR; international normalized ratio; MI; myocardial infarction; OAT; oral anticoagulant therapy; OAT-CH; oral anticoagulant therapy conversion to heparin;
Novel oral anticoagulants in non-valvular atrial fibrillation
Keywords: درمان ضد انعقاد خوراکی; atrial fibrillation; stroke; stroke prevention; stroke risk assessment; bleeding risk assessment; oral anticoagulant therapy; vitamin K antagonists; warfarin; novel oral anticoagulants; dabigatran; rivaroxaban; apixaban; net clinical benefit
Prothrombin complex concentrate (PCC, Octaplex®) in patients requiring immediate reversal of vitamin K antagonist anticoagulation
Keywords: درمان ضد انعقاد خوراکی; VKA; Vitamin K antagonist; FFP; Fresh frozen plasma; PCC; Prothrombin complex concentrate; INR; International normalized ratio; OAT; Oral anticoagulant therapy; TACO; Transfusion associated cardiac overload syndrome; TRALI; Transfusion related acute lung
Chronic oral anticoagulant therapy in carotid artery stenting: The un-necessity of perioperative bridging heparin therapy
Keywords: درمان ضد انعقاد خوراکی; CAS; carotid artery stenting; OAT; oral anticoagulant therapy; MI; myocardial infarction; Carotid artery stenosis; Oral anticoagulant therapy; Bridging heparin therapy; Carotid artery stenting;
Regular Article“Zeus” a new oral anticoagulant therapy dosing algorithm : A cohort study
Keywords: درمان ضد انعقاد خوراکی; Oral anticoagulant therapy; Computer assistance; Dosing therapy algorithm;
Esperienza clinica nella gestione dell'emorragia intracranica spontanea in pazienti in terapia con warfarin
Keywords: درمان ضد انعقاد خوراکی; Intracranial haemorrhage; Oral anticoagulant therapy; Prothrombin complex concentrate; Fresh frozen plasma; Recombinant activated factor VII;
Out of hospital anticoagulant therapy in patients with acute pulmonary embolism is frequently practised but not perfect
Keywords: درمان ضد انعقاد خوراکی; PE; pulmonary embolism; INR; international normalised ratio; LMWH; low-molecular-weight heparin; OAT; oral anticoagulant therapy; TBR; Time below range (INRÂ <Â 2.0); TIR; Time in therapeutic range (INR 2.0 - 3.5); TAR; Time above range (INRÂ >Â 3.5); T
Unprovoked Venous Thromboembolism: Short term or Indefinite Anticoagulation? Balancing Long-Term Risk and Benefit
Keywords: درمان ضد انعقاد خوراکی; Venous thromboembolism; Unprovoked; Oral anticoagulant therapy; Clinical decision rules; Recurrence; Major bleeding; Case-fatality rates
Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
Keywords: درمان ضد انعقاد خوراکی; Atrial fibrillation; Current treatment practices; Guidelines; Oral anticoagulant therapy; Stroke risk;
Gestion périopératoire des AVK
Keywords: درمان ضد انعقاد خوراکی; Thrombose; Hémorragie; Anti-vitamines K; Héparine; Chirurgie; Thrombosis; Hemorrhage; Oral anticoagulant therapy; Heparin; Surgery;
Risk of bleeding in very old atrial fibrillation patients on warfarin: Relationship with ageing and CHADS2 score
Keywords: درمان ضد انعقاد خوراکی; Atrial fibrillation; Old patients; Bleeding risk; Oral anticoagulant therapy; CHADS2 score
Consultation de pharmacie et niveau de connaissance des patients hospitalisés traits par des médicaments anti-vitamine K
Keywords: درمان ضد انعقاد خوراکی; Consultation de pharmacie; Ãducation des patients; Anticoagulants oraux; Pharmaceutical counselling; Patient education; Oral anticoagulant therapy;
Is Recurrent Venous Thromboembolism After Therapy Reduced by Low-Molecular-Weight Heparin Compared With Oral Anticoagulants?
Keywords: درمان ضد انعقاد خوراکی; deep vein thrombosis; low-molecular-weight heparin; oral anticoagulant therapy; venous thromboembolism; vitamin k antagonistsCI, confidence interval; DVT, deep vein thrombosis; INR, international normalized ratio; ITT, intention to treat; LMWH, low-molecu
Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation
Keywords: درمان ضد انعقاد خوراکی; Patient self-management; Oral anticoagulant therapy; International Normalised Ratio; Coagulometer; International consensus guidelines;